Ose Immunotherapeutics

Ose Immunotherapeutics est une entreprise française de biotechnologie dont le siège est à Nantes en France. Elle développe différents types d'immunothérapies.

Filings

8 filings

All Inside information96 Voting rights and capital15 Earnings release10 AGM documents8 Threshold crossing5 Share buyback4 Universal registration document3 Half-year financial report1

03/06/2026
Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting
AGM documentsFR
09/09/2025
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025
AGM documentsFR
09/06/2025
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
AGM documentsFR
04/06/2025
Ose Immunotherapeutics : Documents made available to the shareholders for the combined general meeting of June 25th, 2025
AGM documentsFR

About

ISIN: FR0012127173
Ticker: OSE
LEI: 969500HIUWVGY6NZSM05
Sector: Health care
Founded: 2016
Country of registration: FR
Last filing: 08/07/2026, 18:00

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive